@article{68a940d9929a40089540dd6ee3126d25,
title = "Long-Term Remissions Observed in an Ongoing Phase 2 Study of Brentuximab Vedotin in Patients with Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma.",
author = "Barbara Pro and Advani, \{Ranjana H.\} and Pauline Brice and Bartlett, \{Nancy L.\} and Rosenblatt, \{Joseph D.\} and Tim Illidge and Matous, \{Jeffrey V.\} and Radhakrishnan Ramchandren and Fanale, \{Michelle A.\} and Connors, \{Joseph M.\} and Yin Yang and Kennedy, \{Dana A.\} and Shustov, \{Andrei R.\}",
note = "624. Lymphoma - Therapy with Biologic Agents, excluding Pre-Clinical Models: Poster II | Barbara Pro, Ranjana H. Advani, Pauline Brice, Nancy L. Bartlett, Joseph D. Rosenblatt, Tim Illidge, Jeffrey V. Matous, Radhakrishnan Ramchandren, Michelle A. Fanale, Joseph M. Connors, Yin Yang, Dana A. Kennedy, Andrei R.",
year = "2012",
month = nov,
day = "16",
doi = "10.1182/BLOOD.V120.21.2745.2745",
language = "American English",
volume = "120",
journal = "Blood",
publisher = "American Society of Hematology",
number = "21",
}